vs
Purple Innovation, Inc.（PRPL）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Purple Innovation, Inc.的1.5倍（$207.3M vs $140.7M），Purple Innovation, Inc.净利率更高（-2.3% vs -62.0%，领先59.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.1%），Purple Innovation, Inc.自由现金流更多（$-7.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 8.3%）
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PRPL vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.7M | $207.3M |
| 净利润 | $-3.2M | $-128.6M |
| 毛利率 | 41.9% | — |
| 营业利润率 | -1.6% | -54.7% |
| 净利率 | -2.3% | -62.0% |
| 营收同比 | 9.1% | 25.9% |
| 净利润同比 | 62.1% | 3.5% |
| 每股收益（稀释后） | $0.03 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $140.7M | $207.3M | ||
| Q3 25 | $118.8M | $159.9M | ||
| Q2 25 | $105.1M | $166.5M | ||
| Q1 25 | $104.2M | $139.3M | ||
| Q4 24 | $129.0M | $164.6M | ||
| Q3 24 | $118.6M | $139.5M | ||
| Q2 24 | $120.3M | $147.0M | ||
| Q1 24 | $120.0M | $108.8M |
| Q4 25 | $-3.2M | $-128.6M | ||
| Q3 25 | $-11.7M | $-180.4M | ||
| Q2 25 | $-17.3M | $-115.0M | ||
| Q1 25 | $-19.1M | $-151.1M | ||
| Q4 24 | $-8.5M | $-133.2M | ||
| Q3 24 | $-39.2M | $-133.5M | ||
| Q2 24 | $27.0K | $-131.6M | ||
| Q1 24 | $-50.2M | $-170.7M |
| Q4 25 | 41.9% | — | ||
| Q3 25 | 42.8% | — | ||
| Q2 25 | 35.9% | — | ||
| Q1 25 | 39.4% | — | ||
| Q4 24 | 42.9% | — | ||
| Q3 24 | 29.7% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | 34.8% | — |
| Q4 25 | -1.6% | -54.7% | ||
| Q3 25 | -10.2% | -106.9% | ||
| Q2 25 | -13.5% | -64.8% | ||
| Q1 25 | -13.9% | -102.6% | ||
| Q4 24 | -6.0% | -74.3% | ||
| Q3 24 | -39.5% | -94.6% | ||
| Q2 24 | -12.1% | -79.1% | ||
| Q1 24 | -19.3% | -151.9% |
| Q4 25 | -2.3% | -62.0% | ||
| Q3 25 | -9.9% | -112.8% | ||
| Q2 25 | -16.5% | -69.0% | ||
| Q1 25 | -18.4% | -108.5% | ||
| Q4 24 | -6.6% | -80.9% | ||
| Q3 24 | -33.1% | -95.7% | ||
| Q2 24 | 0.0% | -89.5% | ||
| Q1 24 | -41.8% | -156.8% |
| Q4 25 | $0.03 | $-1.28 | ||
| Q3 25 | $0.11 | $-1.81 | ||
| Q2 25 | $0.16 | $-1.17 | ||
| Q1 25 | $0.18 | $-1.57 | ||
| Q4 24 | $0.08 | $-1.34 | ||
| Q3 24 | $0.36 | $-1.40 | ||
| Q2 24 | $0.00 | $-1.52 | ||
| Q1 24 | $0.47 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $24.3M | $421.0M |
| 总债务越低越好 | $126.7M | — |
| 股东权益账面价值 | $-29.7M | $-80.0M |
| 总资产 | $296.3M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $24.3M | $421.0M | ||
| Q3 25 | $32.4M | $202.5M | ||
| Q2 25 | $34.2M | $176.3M | ||
| Q1 25 | $21.6M | $127.1M | ||
| Q4 24 | $29.0M | $174.0M | ||
| Q3 24 | $23.4M | $150.6M | ||
| Q2 24 | $23.4M | $480.7M | ||
| Q1 24 | $34.5M | $112.3M |
| Q4 25 | $126.7M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $70.7M | — | ||
| Q3 24 | $50.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-29.7M | $-80.0M | ||
| Q3 25 | $-26.9M | $9.2M | ||
| Q2 25 | $-15.6M | $151.3M | ||
| Q1 25 | $1.3M | $144.2M | ||
| Q4 24 | $20.2M | $255.0M | ||
| Q3 24 | $28.0M | $346.8M | ||
| Q2 24 | $66.4M | $432.4M | ||
| Q1 24 | $65.5M | $140.3M |
| Q4 25 | $296.3M | $1.5B | ||
| Q3 25 | $302.1M | $1.2B | ||
| Q2 25 | $303.8M | $1.3B | ||
| Q1 25 | $293.8M | $1.3B | ||
| Q4 24 | $307.8M | $1.5B | ||
| Q3 24 | $309.3M | $1.5B | ||
| Q2 24 | $362.1M | $1.6B | ||
| Q1 24 | $382.1M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.50× | — | ||
| Q3 24 | 1.82× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-7.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | -5.5% | -48.6% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-5.8M | $-99.8M | ||
| Q3 25 | $-968.0K | $-91.4M | ||
| Q2 25 | $-4.0M | $-108.3M | ||
| Q1 25 | $-23.1M | $-166.5M | ||
| Q4 24 | $6.8M | $-79.3M | ||
| Q3 24 | $1.1M | $-67.0M | ||
| Q2 24 | $-8.9M | $-77.0M | ||
| Q1 24 | $-16.8M | $-190.7M |
| Q4 25 | $-7.8M | $-100.8M | ||
| Q3 25 | $-1.8M | $-92.7M | ||
| Q2 25 | $-7.0M | $-110.7M | ||
| Q1 25 | $-25.3M | $-167.8M | ||
| Q4 24 | $5.7M | $-79.5M | ||
| Q3 24 | $101.0K | $-68.6M | ||
| Q2 24 | $-11.0M | $-79.0M | ||
| Q1 24 | $-19.9M | $-193.9M |
| Q4 25 | -5.5% | -48.6% | ||
| Q3 25 | -1.5% | -58.0% | ||
| Q2 25 | -6.6% | -66.5% | ||
| Q1 25 | -24.3% | -120.5% | ||
| Q4 24 | 4.4% | -48.3% | ||
| Q3 24 | 0.1% | -49.2% | ||
| Q2 24 | -9.2% | -53.7% | ||
| Q1 24 | -16.5% | -178.2% |
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 0.7% | 0.8% | ||
| Q2 25 | 2.8% | 1.5% | ||
| Q1 25 | 2.2% | 1.0% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 0.9% | 1.2% | ||
| Q2 24 | 1.7% | 1.4% | ||
| Q1 24 | 2.5% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -330.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
